Clinical study exploring effect difference verification to evaluate the effectiveness of sarcopenia monitoring system

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CRIS

Registry ID

KCT0010916

Enrollment

Registered

2025-08-19

Start date

2024-10-30

Completion date

Unknown

Last updated

2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : The digital biomarkers used in the “clinical research–grade” digital medical device sarcopenia monitoring system, the Rebone application, consist of the following: STS (Sit to Stand)

Rapid Tapping for grip strength measurement

the Arm Curl Test from the Senior Fitness Test (SFT)

and the Timed Up and Go (TUG) test to assess lower extremity function. The performance of these digital biomarkers was validated through prior studies, including Verification and Analytical Validation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: • Adults aged 60 years or older • Individuals weighing 35 kg or more • Individuals who have provided informed consent to participate in this test • Users of Android-based devices • Individuals without difficulty walking • Individuals capable of performing physical activity/exercise • Individuals with no hearing impairments • Individuals whose native language is Korean and who can read and understand written Korean

Exclusion criteria

Exclusion criteria: • Individuals who have had a serious illness affecting gait within the past 1 year • Individuals who require assistance from others for daily living activities • Individuals who have had a fracture of the limbs within the past 6 months • Individuals with severe mental illness such as depression or anxiety disorder, or who are currently taking antidepressants or related medications • Individuals with underlying muscle diseases, including muscular dystrophy • Individuals with Type 1 diabetes or uncontrolled Type 2 diabetes • Individuals with dyspnea classified as grade 2 or higher on the Medical Research Council Dyspnea Scale, or diagnosed with chronic obstructive pulmonary disease (COPD) • Individuals with systemic autoimmune diseases • Individuals currently undergoing treatment for active cancer • Individuals with chronic active infections • Individuals who abuse drugs or alcohol • Individuals with creatinine levels exceeding twice the upper limit of normal

Design outcomes

Primary

Measure	Time frame
Sarcopenia diagnosis result	—

Secondary

Measure	Time frame
SPPB(Short Physical Performance Battery);Rehave Application data	—

Countries

Korea, Republic of

Contacts

Public ContactChung YunSoo

Yonsei University Health System, Severance Hospital

espera88@yuhs.ac+82-2-2228-2232

Outcome results